Paper9701245
Regenerating functional myocardium: improved performance after skeletal myoblast transplantation.
Taylor DA and 7 others. Nat Med, 1998. Cited by 818 papers, by iCite.
Cite this record
ConductScience Library. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Papers, record 9701245. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9701245
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transplantation | Major topic |
| Heart | Major topic |
| Muscle, Skeletal | Major topic |
| Myocardial Infarction | Major topic |
| Myocardium | Major topic |
| Regeneration | Major topic |
| Animals | |
| Cells, Cultured | |
| Freezing | |
| Microscopy, Electron | |
| Rabbits |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2R01HL5798-01 | NHLBI NIH HHS | United States | R01HL579801 | PubMed |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05043610 | MSCs for Prevention of MI-induced HF | Background |
Source ClinicalTrials.gov
Cited by220
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 818 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40940801 | Cardiac Development, Cellular Composition and Function: From Regulatory Mechanisms to Applications. | Cells | 2025 | https://conductscience.org/library/papers/40940801 | PubMed |
| 40494424 | Optogenetic mitochondrial preconditioning enhances cardiomyocyte survival under stress. | J Mol Cell Cardiol | 2025 | https://conductscience.org/library/papers/40494424 | PubMed |
| 39076280 | Healing the Ischaemic Heart: A Critical Review of Stem Cell Therapies. | Rev Cardiovasc Med | 2023 | https://conductscience.org/library/papers/39076280 | PubMed |
| 38337808 | Time-Sequential Monitoring of the Early Mesothelial Reaction in the Pleura after Cryoinjury. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/38337808 | PubMed |
| 37740221 | Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial. | Stem Cell Res Ther | 2023 | https://conductscience.org/library/papers/37740221 | PubMed |
| 37365262 | Remodeled eX vivo muscle engineered tissue improves heart function after chronic myocardial ischemia. | Sci Rep | 2023 | https://conductscience.org/library/papers/37365262 | PubMed |
| 37098611 | Engineering of MSCs sheet for the prevention of myocardial ischemia and for left ventricle remodeling. | Stem Cell Res Ther | 2023 | https://conductscience.org/library/papers/37098611 | PubMed |
| 37048163 | Preclinical Large Animal Porcine Models for Cardiac Regeneration and Its Clinical Translation: Role of hiPSC-Derived Cardiomyocytes. | Cells | 2023 | https://conductscience.org/library/papers/37048163 | PubMed |
| 36672578 | New Opportunities in Heart Failure with Preserved Ejection Fraction: From Bench to Bedside… and Back. | Biomedicines | 2022 | https://conductscience.org/library/papers/36672578 | PubMed |
| 35927674 | Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8). | Trials | 2022 | https://conductscience.org/library/papers/35927674 | PubMed |
| 35461308 | Signaling cascades in the failing heart and emerging therapeutic strategies. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35461308 | PubMed |
| 35413932 | Single vs. double intracoronary injection of mesenchymal stromal cell after acute myocardial infarction: the study protocol from a randomized clinical trial: BOOSTER-TAHA7 trial. | Trials | 2022 | https://conductscience.org/library/papers/35413932 | PubMed |
| 35326403 | Optogenetic Control of Engrafted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Live Mice: A Proof-of-Concept Study. | Cells | 2022 | https://conductscience.org/library/papers/35326403 | PubMed |
| 35231426 | Heart regeneration: 20 years of progress and renewed optimism. | Dev Cell | 2022 | https://conductscience.org/library/papers/35231426 | PubMed |
| 35136722 | The challenges and optimization of cell-based therapy for cardiovascular disease. | J Transl Int Med | 2021 | https://conductscience.org/library/papers/35136722 | PubMed |
| 35013648 | [Cardiac cell therapy-Lost in translation?] | Z Herz Thorax Gefasschir | 2022 | https://conductscience.org/library/papers/35013648 | PubMed |
| 34884909 | Cardiac Remodeling and Repair: Recent Approaches, Advancements, and Future Perspective. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34884909 | PubMed |
| 34858202 | Remote Hind-Limb Ischemia Mechanism of Preserved Ejection Fraction During Heart Failure. | Front Physiol | 2021 | https://conductscience.org/library/papers/34858202 | PubMed |
| 34630860 | Stem cell therapies in cardiac diseases: Current status and future possibilities. | World J Stem Cells | 2021 | https://conductscience.org/library/papers/34630860 | PubMed |
| 34568321 | Regenerative Medicine for the Treatment of Ischemic Heart Disease; Status and Future Perspectives. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34568321 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9701245
GET https://conductscience.org/api/papers/v1/9701245/cited_by?page=2